Your browser doesn't support javascript.
loading
Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder.
Yang, Jian; Zhou, Jingjing; Zhou, Jia; Wang, Haixia; Sun, Zuoli; Zhu, Xuequan; He, Yi; Wong, Albert H C; Liu, Fang; Wang, Gang.
Afiliación
  • Yang J; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, Beijing, China.
  • Zhou J; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, Beijing, China.
  • Zhou J; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Wang H; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Sun Z; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Zhu X; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • He Y; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Wong AHC; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Liu F; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, Beijing, China; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: fang.liu@camh.ca.
  • Wang G; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, Beijing, China. Electro
J Psychiatr Res ; 146: 172-178, 2022 02.
Article en En | MEDLINE | ID: mdl-34995992
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Componente Amiloide P Sérico / Trastorno Depresivo Mayor / Escitalopram Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Psychiatr Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Componente Amiloide P Sérico / Trastorno Depresivo Mayor / Escitalopram Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Psychiatr Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido